Our aim was to detect the presence of an alternative oxidase (AOX) in Candida krusei clinical strains and its influence on fluconazole susceptibility and in reactive oxygen species (ROS) production. Candida krusei clinical isolates were tested to evaluate the presence of AOX. Debaromyces hansenii 2968 (AOX positive) and Saccharomyces cerevisiae BY4742 (AOX negative) were used as control strains. Measurements of oxygen consumption were performed in the presence of 1 mM KCN, an inhibitor of the classical respiratory chain, and 5 mM salicylhydroxamic acid (SHAM). AOX expression was monitored by Western blotting using an AOX monoclonal antibody. Interactions between fluconazole and SHAM were performed using checkerboard assay. ROS production was evaluated in the presence of SHAM plus fluconazole, H 2 O 2 , menadione, or plumbagin. AOX was present in all C. krusei tested. The combination of fluconazole with SHAM resulted in an indifferent effect. In the presence of SHAM, the treatment with ROS inductors or fluconazole increased ROS production, except in the AOX-negative strain. An alternative respiratory pathway resistant to cyanide is described for the first time as a characteristic of C. krusei species. This AOX is unrelated to fluconazole resistance; however, it protects C. krusei from oxidative stress.
Introduction
Over the past few decades, authors have documented increases in the rate of candidemia by non-albicans species of Candida, such as Candida krusei, especially in critically ill and immunocompromised patients with hematologic malignancies (Hachem et al., 2008) .
Fluconazole is often used in the prophylaxis and treatment of candidemia and is the first-line therapy for this condition (Pappas et al., 2009) . Among non-albicans species, C. krusei is the only species that is predictably fluconazole resistant (Oxman et al., 2010) . Antifungal drug tolerance can also be modulated by metabolic adaptability mechanisms, including alterations in the respiratory mitochondrial pathway (Chamilos et al., 2006; Brun et al., 2003) . This fact had been previously assessed in C. glabrata, C. albicans, and C. parapsilosis regarding its influence on fluconazole and caspofungin (Brun et al., 2003; Chamilos et al., 2006; Yan et al., 2009) .
In eukaryotic organisms, the energy necessary for growth, development, reproduction, and stress response is acquired through the ATP synthesized during mitochondrial respiration, where cytochrome c oxidase acts as a terminal oxidase in the reception of electrons and converting oxygen into water. Within the mitochondrial respiratory chain, another route mediated by the alternative oxidase (AOX; a mitochondrial enzyme) can be found in plants, in certain protozoa and fungi (Moore & Siedow, 1991; Helmerhorst et al., 2002 Helmerhorst et al., , 2005 Veiga et al., 2003a, b) . This AOX is insensitive to cytochrome pathway inhibitors, such as antimicin A or cyanide, but is specifically inhibited by salicylhydroxamic acid (SHAM) and confers a cyanide-resistant respiration through an alternative respiratory pathway (ARP) to such organisms (Moore Siedow, 1991) . The AOX is located on the matrix side of the inner mitochondrial membrane and plays an important role in susceptibility to azole antifungals in C. albicans (Yan et al., 2009) . The alternative respiratory chain can be activated by stress situations like the presence of antifungals or oxidative inductors, thus leading to drug tolerance and to the reduction in generation of intracellular reactive oxygen species (ROS; Cannon et al., 2007) .
In an attempt to explain the contribution of mitochondrial respiration in the intrinsic fluconazole resistance displayed by C. krusei, we assessed the existence of an ARP and its influence upon fluconazole resistance and tolerance to oxidative stress in C. krusei.
Materials and methods

Drugs and chemicals
Fluconazole was obtained from Pfizer (Groton, CT), and stock solutions were prepared according to CLSI M27 A3 protocol and maintained at À70°C until use (CLSI, 2008) . Stock solutions of SHAM (200 mM; SigmaAldrich, Germany) and potassium cyanide (KCN, 1 M; Sigma) were prepared in DMSO (Sigma) and distilled water, respectively. Hydrogen peroxide (H 2 O 2 ; 30% v/v) was obtained from Merck. Plumbagin and menadione were obtained from Sigma, and stock solutions (100 mM) were prepared in 95% ethanol. Dihydrorhodamine 123 (DHR123) was obtained from Molecular Probes (Eugene, OR).
Strains and culture conditions
A total of 25 C. krusei (nine from respiratory secretions, one from blood, 11 vaginal, three fecal, and the type strain ATCC 6258 from the American Type Culture Collection), previously identified using VITEK II system (BioMérieux, Paris, France), all resistant to fluconazole were used in this study. Candida albicans SC5314 strain was used as positive control for the presence of AOX-specific protein. The strains were grown in Sabouraud dextrose broth (Difco) at 30°C, in an orbital shaker at 150 r.p.m. until late exponential growth phase (OD 640 1.5). Debaromyces hansenii IGC2968 (LGC Standards S.L. U., Barcelona, Spain) was used as the positive control for the presence of an ARP, assessed by oxygen consumption. Saccharomyces cerevisiae BY4742 (EUROSCARF, Frankfurt, Germany) was used throughout the study as the negative control for the presence of the AOX assessed by oxygen consumption, immunoblotting, and ROS production. These control strains were grown in a mineral medium with vitamins and 2% (w/v) glucose until stationary growth phase (OD 640 2.5 and 3, respectively; Veiga et al., 2003a, b) .
Alternative respiratory pathway
Late exponential phase cultures were centrifuged (18 000 g) for 4 min at 4°C and washed twice with cold sterile water. An small amount (1.5 g wet weight) of pellet was resuspended in 100 mL of 50 mM phosphate-buffered saline, pH 6.0 with 0.1% cicloheximide (Sigma, St. Louis, MO), and 6 mL of suspension was incubated in a small reactor at 28°C. The O 2 consumption was continuously measured with a Clark-type electrode YSI model 5775 (YSI Incorporated, Yellow Springs, OH) after the addition of 200 lL of 1.55 M glucose (Difco Laboratories, Detroit, MI), 3.2 mM of KCN, and/or 3.2 mM of SHAM (Sigma-Aldrich). The presence of an AOX was considered whenever the oxygen consumption pattern was resistant to KCN, but sensitive to SHAM.
Checkerboard microdilution assay
Checkerboard assays were performed with all C. krusei strains, in the presence of fluconazole and SHAM, using the protocol described in the Clinical Microbiology Procedures Handbook (Moody, 1991) . The concentration range used was 0.125-64 lg fluconazole mL The interpretation of FIX was as recommended: 0.5, synergistic effect; > 0.5 to < 4.0, no interaction; ! 4.0, antagonistic effect (Moody, 1991) .
Assessment of intracellular ROS accumulation
Intracellular ROS accumulation was estimated to study the influence of an AOX upon C. krusei oxidative stress tolerance. After being washed and resuspended in PBS, 10 7 cells mL À1 were treated with ROS inductors such as DMSO concentration similar to that used in cell samples pretreated with SHAM. The cells were then collected by centrifugation and resuspended in PBS. Free intracellular ROS were detected with 15 lg dihydrorhodamine 123 mL À1 (Molecular Probes; Almeida et al., 2007; Mesquita et al., 2010) . Cells were incubated during 90 min at 30°C in the dark, washed in PBS, and 5 lL was placed in a glass slide and overlapped with vectashield fluorescence mounting media (Vector Laboratories, Peterborough, UK). The stained suspensions were visualized under epifluorescence microscopy (409; Olympus BX61).
In each condition, a minimum of 500 cells from three different replicates were counted, and the percentage of stained cells (cells displaying ROS) was determined.
Chronological life span
Overnight cultures of C. krusei strains were incubated in YPD broth until stationary phase (day 0 of chronological life span; Mesquita et al., 2010). Cultures were treated without (control) and with 3.2 mM SHAM, 0.25 mM, and 0.5 mM of menadione alone, and in combination with 3.2 mM of SHAM. Survival was assessed daily by counting colony-forming units (CFUs) from cultures aliquots in YPD agar plates beginning at day 0 (when viability was considered to be 100%).
Preparation of mitochondrial extracts
Mitochondrial extracts were isolated from S. cerevisiae, Candida albicans SC5314, and C. krusei. Cells were grown to stationary phase, harvested, and cell wall was digested with zymolyase buffer [2 M sorbitol-D, phosphate buffer 1 M (pH 7.5), zymolyase 20 000 U, 125 mM b-mercaptoethanol, 0.5 M EDTA] at 30°C for 1 h. Protoplasts were disrupted with lysis buffer [sorbitol-D 0.5 M, Tris 20 mM, EDTA 1 mM, and 2.85 mM phenylmethanesulphonyl fluoride (PMSF)] using a Potter homogenizator. Mitochondrial extracts were separated, washed by highspeed centrifugation at 16 420 g for 15 min at 4°C (Beckman Coulter, JA-25.50 Rotor), and resuspended in sorbitol buffer (0.5 sorbitol-D, 5 mM EDTA, 50 mM Tris). Protein concentration was determined by Bradford method (Kruger, 1994) , and protein aliquots of mitochondrial extracts (40 lg) were stored at À20°C.
Immunoblotting
Mitochondrial protein extracts were resolved on a 12% SDS gel and transferred to a nitrocellulose membrane. The membrane was blocked with phosphate-buffered saline (TBS) with 0.1% Tween 20 (TBST) containing 5% skim milk, followed by incubation with antibodies against AOX proteins (1 : 100) of Sauromatum guttatum (Agrisera AB, Vännas, Sweden) in TBST containing 1% skim milk. After washing with TBS, the membranes were incubated with the respective secondary antibody, HRP-conjugated anti-mouse IgG at a dilution of 1 : 5000, and detected by enhanced chemiluminescence.
Statistical analysis
All experiments were performed in triplicate. Mean values were compared using Student's t-test whenever indicated. A P value < 0.05 was considered statistically significant.
Results
Presence of a cyanide-resistant respiration pathway in C. krusei
To investigate whether an ARP was present in clinical isolates of C. krusei, measurements of O 2 consumption were performed in the presence of 3.2 mM of cyanide, an inhibitor of the classical respiratory chain (by inhibiting the cytochrome c oxidase complex), and SHAM, an inhibitor of the ARP (by inhibiting the AOX). In C. krusei strains, O 2 consumption stopped only after the addition of SHAM (Fig. 1a , representative example). This observation was made for all the 24 C. krusei clinical isolates, with ATCC 6258 type strain and with the positive AOX control strain Debaromyces hansenii 2968 (Fig. 1b) . In Saccharomyces cerevisiae BY4742, the negative AOX control strain, the oxygen consumption stopped soon after the addition of cyanide (Fig. 1c) .
The results indicate that C. krusei cells have a cyanideresistant respiration pathway promoted by the presence of an AOX.
AOX expression
Mitochondrial preparations were immunoblotted with a monoclonal antibody raised against S. guttatum AOX, but also recognize C. albicans AOX (Huh & Kang, 1999) . In all C. krusei clinical isolates, mitochondrial AOX was clearly detectable as well as in C. albicans SC5314 strain (Fig. 2) . Mitochondria isolated from the negative control strain, S. cerevisiae BY4742, showed no reactivity with AOX antiserum (Fig. 2) .
Fluconazole-SHAM combination did not influence fluconazole activity
To study the influence of the ARP upon fluconazole resistance by C. krusei, we explored the in vitro combination The presence of an alternative respiratory pathway in C. krusei relates to reduced ROS accumulation
To assess the influence of the ARP upon oxidative stress response, we measured intracellular ROS accumulation with and without SHAM, using DHR123. This fluorochrome enters the yeast cell as a freely permeable dye, which is converted to rhodamine 123 and subsequently localized in the mitochondria. The conversion from the nonfluorescent to the fluorescent molecule is entirely dependent upon the presence of oxidation products. After treatment with the ROS-inducing agents, H 2 O 2 , plumbagin, menadione, and with azoles, the percentage of stained cells (cells with ROS accumulation) was calculated and compared with values displayed by nontreated cells, in the presence and absence of SHAM (3.2 mM). No significant differences regarding ROS accumulation were observed with the AOX-negative strain, S. cerevisiae BY4742, in the presence or in the absence of SHAM (Fig. 3) . In contrast, after treatment with ROS-inducing agents, C. krusei cells treated with SHAM produced significantly (P < 0.001) more endogenous ROS than the cells with the unblocked ARP (without SHAM; Fig. 3 ). Significant differences in ROS production (P = 0.008) were also accomplished with fluconazole (Fig. 3) . All C. krusei-tested strains displayed similar results. Chronological life span decreased in C. krusei strains incubated with menadione when compared with untreated cultures (Fig. 4) . The viability of C. krusei strains reduced significantly after 3 days of incubating the cultures with menadione plus SHAM (Fig. 4) .
Discussion
Several authors have stressed the relevance of the mitochondrial respiration and its influence upon metabolic behavior, stress environment adaptability, and antifungal drug tolerance (Brun et al., 2003; Chamilos et al., 2006; Yan et al., 2009; Li et al., 2011) . A mitochondrial ARP (cyanine-resistant) occurs in all higher plants, in many fungi, and in some protozoa (Kirimura et al., 1999; Johnson et al., 2003) . Such a pathway uses electrons from the ubiquinol pool to reduce oxygen to water, bypassing the complex III and the cytochrome oxidase complex, two sites of energy conservation in the main respiratory chain. An AOX, sensitive to SHAM and resistant to cyanide, is responsible for this alternative pathway (McIntosh, 1994) . The cyanide-resistant respiration has been previously described in C. albicans and C. parapsilosis (Helmerhorst et al., 2002; Chamilos et al., 2006; Yan et al., 2009) . In this study, we described for the first time the presence of an ARP mediated by an AOX in C. krusei. The elucidation of the oxidative stress responses in yeast has considerable clinical interest, as it is involved in invasion and colonization of host tissues by yeast pathogens as well as during the defensive mechanisms triggered by phagocytes. All aerobic organisms inevitably generate a range of ROS, including superoxide anion, hydrogen peroxide, and hydroxyl radical during oxygen metabolism. If not quickly and effectively eliminated from the cells, ROS will trigger a large number of oxidative reactions in cellular systems that possibly lead to cell death (Raha & Robinson, 2000) . In the course of an in vivo infection, the formation of ROS and other oxidants radicals by phagocytes plays a crucial role in the intracellular destruction of the pathogen (Murphy, 1991) . ROS attack almost all essential cell components, including DNA, proteins, and lipids (Moradas-Ferreira & Costa, 2000) . In a recent study, C. krusei appears to be resistant to ROS and to possess a potent antioxidant system enabling deep systemic infections (Abegg et al., 2010) . We decided to evaluate the difference regarding oxidative stress response before and after the blockade of the ARP. It has been previously described that in C. albicans, fluconazole is able to induce the production and accumulation of ROS (Kobayashi et al., 2002) . In our study, we showed that fluconazole induced a low percentage of ROS formation by C. krusei cells. These results may suggest that the fungistatic mechanism of this azole is not based upon ROS formation. However, when the AOX was inhibited by SHAM, an increase in the intracellular ROS levels was evident. Attending to these facts, we can conclude that AOX activity allows the yeast cells to reduce ROS accumulation when challenged by antifungals like fluconazole, leading to drug tolerance, like in C. albicans (Yan et al., 2009) . According to several authors, the AOX has a metabolic and antioxidant role, and its presence may be considered a potential virulence attribute of pathogenic fungi (Vanlerberghe et al., 2002; Missall et al., 2004; Yan et al., 2009) . The importance of AOX activity upon resistance to oxidative stress was evident when the oxidative stress inductors, H 2 O 2 , menadione, and plumbagin, were assayed. After treatment with such compounds, ROS accumulation was low. However, the scenario changed significantly when the AOX activity was blocked by SHAM. To confirm our hypothesis that the presence of an ARP could protect C. krusei from oxidative stress, we assessed ROS accumulation in the presence of fluconazole and the other oxidative stress inductors by the negative control strain, S. cerevisiae (AOX-). The results obtained regarding ROS accumulation, in the presence or absence of SHAM, were not significantly different. When testing C. albicans AOX mutant strains, Yan and coworkers also obtained no significant differences in the amount of ROS generation (Yan et al., 2009) . Regarding the chronological life span assays, we could conclude that the decreased viability of C. krusei strains in the presence of menadione and with the AOX blocked is associated with an increased level of cell ROS. Our results showed clearly that the inhibition of the expression of the AOX was associated with intracellular ROS accumulation, revealing the effect of the ARP on oxidative damage. Although fluconazole resistance was unrelated to the presence of the ARP, we can consider that it confers antifungal tolerance, which may give yeast cells enough time to develop long-term genetically stable resistance mechanisms (Cannon et al., 2009) .
The ARP is a potential target that should be taken into account when considering the development of new therapeutic strategies in the case of C. krusei infections. Attending to its selective effect, SHAM should be used in combination with azoles, to reduce resistance because of oxidative stress and consequently the virulence of C. krusei. 
